Acasă

FDA approves first once-weekly drug treatment regimen for hemophilia

Pfizer

Oct. 11 (UPI) -- Patients suffering from hemophilia received a "meaningful" advancement on Friday when federal regulators approved the first once-weekly treatment for the disease. Hympavzi, made by Pfizer, is the first antitissue-factor pathway inhibitor to be approved for the blood-clotting disorder, as well as the first hemophilia drug to offer a once-weekly treatment regimen. Now it has been given the nod by the Food and Drug Administration , the agency announced . Advertisement Pfizer's new

Tag-uri: Pfizer

din zilele anterioare

FDA approves first once-weekly drug treatment regimen for hemophilia https://www.upi.com - 12.10.2024 00:50
STIRILE OREI
Perplexity blasts media as ‘adversarial’ in response to copyright lawsuit Perplexity blasts media as ‘adversarial’ in response to copyright lawsuit https://www.theverge.com - 12:10
Perplexity blasts media as ‘adversarial’ in response to copyright lawsuit Perplexity blasts media as ‘adversarial’ in response to copyright lawsuit https://www.theverge.com - 12:10
Perplexity blasts media as ‘adversarial’ in response to copyright lawsuit Perplexity blasts media as ‘adversarial’ in response to copyright lawsuit https://www.theverge.com/ - 12:10
Istorii corecte politic – Judecata lui Paris Catavencii - 12:05
România, pământ românesc! Economie de piață în piață Catavencii - 12:04
© Copyright 2017 Mediafax SA | Termeni și condiţii | About cookies | Confidentialitate

monitoruldestiri@mediafax.ro

Fotografiile folosite de monitoruldestiri.ro sunt proprietatea Mediafax. Este interzisă republicarea acestora în lipsa unui acord din partea Mediafax. Pentru a obține acest acord, vă rugăm să ne contactați.